Literature DB >> 33436626

Structural insights into TSC complex assembly and GAP activity on Rheb.

Huirong Yang1,2,3,4, Zishuo Yu5, Xizi Chen5, Jiabei Li5, Ningning Li6, Jiaxuan Cheng6, Ning Gao6, Hai-Xin Yuan7, Dan Ye7, Kun-Liang Guan8, Yanhui Xu9,10,11,12.   

Abstract

Tuberous sclerosis complex (TSC) integrates upstream stimuli and regulates cell growth by controlling the activity of mTORC1. TSC complex functions as a GTPase-activating protein (GAP) towards small GTPase Rheb and inhibits Rheb-mediated activation of mTORC1. Mutations in TSC genes cause tuberous sclerosis. In this study, the near-atomic resolution structure of human TSC complex reveals an arch-shaped architecture, with a 2:2:1 stoichiometry of TSC1, TSC2, and TBC1D7. This asymmetric complex consists of two interweaved TSC1 coiled-coil and one TBC1D7 that spans over the tail-to-tail TSC2 dimer. The two TSC2 GAP domains are symmetrically cradled within the core module formed by TSC2 dimerization domain and central coiled-coil of TSC1. Structural and biochemical analyses reveal TSC2 GAP-Rheb complimentary interactions and suggest a catalytic mechanism, by which an asparagine thumb (N1643) stabilizes γ-phosphate of GTP and accelerate GTP hydrolysis of Rheb. Our study reveals mechanisms of TSC complex assembly and GAP activity.

Entities:  

Year:  2021        PMID: 33436626     DOI: 10.1038/s41467-020-20522-4

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  54 in total

1.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.

Authors:  Ken Inoki; Yong Li; Tian Xu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2003-07-17       Impact factor: 11.361

2.  Structure of the TBC1D7-TSC1 complex reveals that TBC1D7 stabilizes dimerization of the TSC1 C-terminal coiled coil region.

Authors:  Zhongchao Gai; Wendan Chu; Wei Deng; Wenqi Li; Hua Li; Ailiang He; Mark Nellist; Geng Wu
Journal:  J Mol Cell Biol       Date:  2016-10-01       Impact factor: 6.216

3.  Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.

Authors:  M van Slegtenhorst; M Nellist; B Nagelkerken; J Cheadle; R Snell; A van den Ouweland; A Reuser; J Sampson; D Halley; P van der Sluijs
Journal:  Hum Mol Genet       Date:  1998-06       Impact factor: 6.150

4.  The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif.

Authors:  Hiroki Nojima; Chiharu Tokunaga; Satoshi Eguchi; Noriko Oshiro; Sujuti Hidayat; Ken-ichi Yoshino; Kenta Hara; Noriaki Tanaka; Joseph Avruch; Kazuyoshi Yonezawa
Journal:  J Biol Chem       Date:  2003-02-25       Impact factor: 5.157

5.  Interaction of GTPase activating proteins (GAPs) with p21ras measured by a novel fluorescence anisotropy method. Essential role of Arg-903 of GAP in activation of GTP hydrolysis on p21ras.

Authors:  G G Brownbridge; P N Lowe; K J Moore; R H Skinner; M R Webb
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

6.  Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins.

Authors:  Yong Zhang; Xinsheng Gao; Leslie J Saucedo; Binggen Ru; Bruce A Edgar; Duojia Pan
Journal:  Nat Cell Biol       Date:  2003-06       Impact factor: 28.824

Review 7.  mTOR Signaling in Growth, Metabolism, and Disease.

Authors:  Robert A Saxton; David M Sabatini
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

8.  Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.

Authors:  Attila Garami; Fried J T Zwartkruis; Takahiro Nobukuni; Manel Joaquin; Marta Roccio; Hugo Stocker; Sara C Kozma; Ernst Hafen; Johannes L Bos; George Thomas
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

9.  TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.

Authors:  Christian C Dibble; Winfried Elis; Suchithra Menon; Wei Qin; Justin Klekota; John M Asara; Peter M Finan; David J Kwiatkowski; Leon O Murphy; Brendan D Manning
Journal:  Mol Cell       Date:  2012-07-12       Impact factor: 17.970

10.  Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.

Authors:  Andrew R Tee; Brendan D Manning; Philippe P Roux; Lewis C Cantley; John Blenis
Journal:  Curr Biol       Date:  2003-08-05       Impact factor: 10.834

View more
  13 in total

1.  The non-essential TSC complex component TBC1D7 restricts tissue mTORC1 signaling and brain and neuron growth.

Authors:  Sandra Schrötter; Christopher J Yuskaitis; Michael R MacArthur; Sarah J Mitchell; Aaron M Hosios; Maria Osipovich; Margaret E Torrence; James R Mitchell; Gerta Hoxhaj; Mustafa Sahin; Brendan D Manning
Journal:  Cell Rep       Date:  2022-05-17       Impact factor: 9.995

2.  The Combination of the CDK4/6 Inhibitor, Palbociclib, With the Vitamin D3 Analog, Inecalcitol, Has Potent In Vitro and In Vivo Anticancer Effects in Hormone-Sensitive Breast Cancer, But Has a More Limited Effect in Triple-Negative Breast Cancer.

Authors:  Justine Vanhevel; Lieve Verlinden; Shauni Loopmans; Stefanie Doms; Iris Janssens; Sien Bevers; Steve Stegen; Hans Wildiers; Annemieke Verstuyf
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

Review 3.  The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging.

Authors:  Stephanie A Fernandes; Constantinos Demetriades
Journal:  Front Aging       Date:  2021-08-27

4.  Amino Acid-Mediated Intracellular Ca2+ Rise Modulates mTORC1 by Regulating the TSC2-Rheb Axis through Ca2+/Calmodulin.

Authors:  Yuna Amemiya; Nao Nakamura; Nao Ikeda; Risa Sugiyama; Chiaki Ishii; Masatoshi Maki; Hideki Shibata; Terunao Takahara
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

Review 5.  The TSC Complex-mTORC1 Axis: From Lysosomes to Stress Granules and Back.

Authors:  Ulrike Rehbein; Mirja Tamara Prentzell; Marti Cadena Sandoval; Alexander Martin Heberle; Elizabeth P Henske; Christiane A Opitz; Kathrin Thedieck
Journal:  Front Cell Dev Biol       Date:  2021-10-29

6.  Single serine on TSC2 exerts biased control over mTORC1 activation mediated by ERK1/2 but not Akt.

Authors:  Brittany L Dunkerly-Eyring; Shi Pan; Miguel Pinilla-Vera; Desirae McKoy; Sumita Mishra; Maria I Grajeda Martinez; Christian U Oeing; Mark J Ranek; David A Kass
Journal:  Life Sci Alliance       Date:  2022-03-14

Review 7.  mTORC1 Crosstalk With Stress Granules in Aging and Age-Related Diseases.

Authors:  Marti Cadena Sandoval; Alexander Martin Heberle; Ulrike Rehbein; Cecilia Barile; José Miguel Ramos Pittol; Kathrin Thedieck
Journal:  Front Aging       Date:  2021-10-13

Review 8.  Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer.

Authors:  Sarah J Backe; Rebecca A Sager; Katherine A Meluni; Mark R Woodford; Dimitra Bourboulia; Mehdi Mollapour
Journal:  Biomolecules       Date:  2022-07-01

9.  Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway.

Authors:  Charles L Evavold; Iva Hafner-Bratkovič; Pascal Devant; Jasmin M D'Andrea; Elsy M Ngwa; Elvira Boršić; John G Doench; Martin W LaFleur; Arlene H Sharpe; Jay R Thiagarajah; Jonathan C Kagan
Journal:  Cell       Date:  2021-07-21       Impact factor: 66.850

10.  Cancer-associated dynamics and potential regulators of intronic polyadenylation revealed by IPAFinder using standard RNA-seq data.

Authors:  Zhaozhao Zhao; Qiushi Xu; Ran Wei; Weixu Wang; Dong Ding; Yu Yang; Jun Yao; Liye Zhang; Yue-Qing Hu; Gang Wei; Ting Ni
Journal:  Genome Res       Date:  2021-09-02       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.